Dissociative Changes in the Bmax and KD of Dopamine D2/D3 Receptors with Aging Observed in Functional Subdivisions of the Striatum: A Revisit with an Improved Data Analysis Method

Separate measurements of Bmax, the density of available receptors, and KD, the equilibrium dissociation constant in the human brain, with PET have contributed to our understanding of neuropsychiatric disorders, especially with respect to the dopamine D2/D3 receptor system. However, existing methods have limited applications to the whole striatum, putamen, or caudate nucleus. Improved methods are required to examine Bmax and KD in detailed functional striatal subdivisions that are becoming widely used. Methods: In response, a new method (bolus-plus-infusion transformation [BPIT]) was developed. After completion of a validation study for 11C-raclopride scans involving 81 subjects, age-associated changes in Bmax and KD were examined in 47 healthy subjects ranging in age from 18 to 77 y. Results: The BPIT method was consistent with established reference tissue methods regarding regional binding potential. BPIT yielded time-consistent estimates of Bmax and KD when scan and infusion lengths were set equal in the analysis. In addition, BPIT was shown to be robust against PET measurement errors when compared with a widely accepted transient equilibrium method. Altogether, BPIT was supported as a method for regional binding potential, Bmax, and KD. We demonstrated age-associated declines in Bmax in all 5 functional striatal subdivisions with BPIT when corrected for multiple comparisons. These age-related effects were not consistently attainable with the transient equilibrium method. Irrespective to methods, KD remained unchanged with age. Conclusion: The BPIT approach may be useful for understanding dopamine receptor abnormalities in neuropsychiatric disorders by enabling separate measurements of Bmax and KD in functional striatal subdivisions.

[1]  C. Meltzer,et al.  Quantification of Neuroreceptors in the Living Human Brain: III. D2-Like Dopamine Receptors: Theory, Validation, and Changes during Normal Aging , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[2]  Tyrone D. Cannon,et al.  Striatal dopamine D1 and D2 receptor balance in twins at increased genetic risk for schizophrenia , 2006, Psychiatry Research: Neuroimaging.

[3]  C. Halldin,et al.  Variability in D2‐dopamine receptor density and affinity: A PET study with [11C]raclopride in man , 1995, Synapse.

[4]  James Robert Brašić,et al.  Relationships Among Ventral Striatal Dopamine Release, Cortisol Secretion, and Subjective Responses to Amphetamine , 2005, Neuropsychopharmacology.

[5]  Osama Mawlawi,et al.  Imaging Human Mesolimbic Dopamine Transmission with Positron Emission Tomography: I. Accuracy and Precision of D2 Receptor Parameter Measurements in Ventral Striatum , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[6]  J. Links,et al.  In Vivo Measurement of Dopamine Receptors in Human Brain by Positron Emission Tomography Age and Sex Differences a , 1988, Annals of the New York Academy of Sciences.

[7]  B. Bogerts,et al.  Reduced volume of limbic system-affiliated basal ganglia in mood disorders: preliminary data from a postmortem study. , 1999, The Journal of neuropsychiatry and clinical neurosciences.

[8]  N. Volkow,et al.  Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[9]  N. Volkow,et al.  Measuring age-related changes in dopamine D2 receptors with 11C-raclopride and 18F-N-methylspiroperidol , 1996, Psychiatry Research: Neuroimaging.

[10]  T G Turkington,et al.  Performance characteristics of a whole-body PET scanner. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  Elliot A. Stein,et al.  Quantification of nicotinic acetylcholine receptors in the human brain with PET: Bolus plus infusion administration of 2-[18F]F-A85380 , 2008, NeuroImage.

[12]  U Ruotsalainen,et al.  Decrease in Human Striatal Dopamine D2 Receptor Density with Age: A PET Study with [11C]Raclopride , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[13]  G. Pearlson,et al.  Quantification of Neuroreceptors in the Living Human Brain: IV. Effect of Aging and Elevations of D2-Like Receptors in Schizophrenia and Bipolar Illness , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[14]  G. Pearlson,et al.  Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. , 1986, Science.

[15]  Hiroto Kuwabara,et al.  Striatal dopamine release and family history of alcoholism. , 2006, Alcoholism, clinical and experimental research.

[16]  A. Lammertsma,et al.  Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.

[17]  Jeih-San Liow,et al.  Linearized Reference Tissue Parametric Imaging Methods: Application to [11C]DASB Positron Emission Tomography Studies of the Serotonin Transporter in Human Brain , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[18]  Gregor Hasler,et al.  Evaluation of a bolus/infusion protocol for 11C-ABP688, a PET tracer for mGluR5. , 2010, Nuclear medicine and biology.

[19]  Zang-Hee Cho,et al.  Effects of age on dopamine D2 receptor availability in striatal subdivisions: A high-resolution positron emission tomography study , 2011, European Neuropsychopharmacology.

[20]  J M Links,et al.  Quantification of Neuroreceptors in the Living Human Brain. II. Inhibition Studies of Receptor Density and Affinity , 1986, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[21]  James Robert Brašić,et al.  The dopamine transporter is decreased in the striatum of subjects with restless legs syndrome. , 2011, Sleep.

[22]  T Greitz,et al.  Preparation of 11C-labelled Raclopride, a new potent dopamine receptor antagonist: preliminary PET studies of cerebral dopamine receptors in the monkey. , 1985, The International journal of applied radiation and isotopes.

[23]  R E Carson,et al.  Regional Brain Measurement of Bmax and KD with the Opiate Antagonist Cyclofoxy: Equilibrium Studies in the Conscious Rat , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[24]  D. Wong,et al.  Column-switching HPLC for the analysis of plasma in PET imaging studies. , 2000, Nuclear medicine and biology.

[25]  R. P. Maguire,et al.  Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[26]  Albert Gjedde,et al.  Mechanisms of Dopaminergic and Serotonergic Neurotransmission in Tourette Syndrome: Clues from an In Vivo Neurochemistry Study with PET , 2008, Neuropsychopharmacology.

[27]  S. Haber,et al.  Imaging Human Mesolimbic Dopamine Transmission with Positron Emission Tomography. Part II: Amphetamine-Induced Dopamine Release in the Functional Subdivisions of the Striatum , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[28]  Päivi Marjamäki,et al.  Age-dependent decline in human brain dopamine D1 and D2 receptors , 1990, Brain Research.

[29]  Mark Slifstein,et al.  Alcohol Dependence Is Associated with Blunted Dopamine Transmission in the Ventral Striatum , 2005, Biological Psychiatry.

[30]  S. Stone-Elander,et al.  D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride. , 1990, Archives of general psychiatry.

[31]  Peter Herscovitch,et al.  Comparison of Bolus and Infusion Methods for Receptor Quantitation: Application to [18F]Cyclofoxy and Positron Emission Tomography , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[32]  Richard E Carson,et al.  Noise Reduction in the Simplified Reference Tissue Model for Neuroreceptor Functional Imaging , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[33]  K. Någren,et al.  Sex differences in the striatal dopamine D2 receptor binding characteristics in vivo. , 1998, The American journal of psychiatry.

[34]  Karl J. Friston,et al.  Human Brain Function , 1997 .

[35]  L. Farde,et al.  Kinetic Analysis of Central [11C]Raclopride Binding to D2-Dopamine Receptors Studied by PET—A Comparison to the Equilibrium Analysis , 1989, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[36]  R. Hales,et al.  J Neuropsychiatry Clin Neurosci , 1992 .

[37]  Karl J. Friston,et al.  Rigid Body Registration , 2003 .

[38]  W C Eckelman,et al.  Measurement of dopamine release with continuous infusion of [11C]raclopride: optimization and signal-to-noise considerations. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[39]  Philip Seeman,et al.  Human brain dopamine receptors in children and aging adults , 1987, Synapse.

[40]  K. Ishii,et al.  Regional analysis of age‐related decline in dopamine transporters and dopamine D2‐like receptors in human striatum , 2009, Synapse.

[41]  K. Någren,et al.  Measurement of Striatal D2 Dopamine Receptor Density and Affinity with [11C]-Raclopride in Vivo: A Test-Retest Analysis , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[42]  Yiyun Huang,et al.  Serotonin Transporter Availability in Patients with Schizophrenia: A Positron Emission Tomography Imaging Study with [11C]DASB , 2005, Biological Psychiatry.